Press Releases Press Releases Year None202320222021202020192018201720162015 Jan 10, 2023 InMed Provides Business Update and Milestones for 2023 Dec 15, 2022 InMed Announces Results of 2022 Annual General Meeting Dec 12, 2022 InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor Nov 21, 2022 InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market Nov 18, 2022 InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market Nov 17, 2022 InMed Provides Update on Management Changes Nov 16, 2022 InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding Nov 11, 2022 InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update Nov 10, 2022 Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022 Oct 26, 2022 InMed Pharmaceuticals Supports Epidermolysis Bullosa Awareness Week Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page › Last page » Displaying 1 - 10 of 227 Investor Alerts Sign up for investor alerts! Sign Up Information Request Send us a request for information Learn More
Press Releases Year None202320222021202020192018201720162015 Jan 10, 2023 InMed Provides Business Update and Milestones for 2023 Dec 15, 2022 InMed Announces Results of 2022 Annual General Meeting Dec 12, 2022 InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor Nov 21, 2022 InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market Nov 18, 2022 InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market Nov 17, 2022 InMed Provides Update on Management Changes Nov 16, 2022 InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding Nov 11, 2022 InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update Nov 10, 2022 Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022 Oct 26, 2022 InMed Pharmaceuticals Supports Epidermolysis Bullosa Awareness Week Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page › Last page » Displaying 1 - 10 of 227